BIORA THERAPEUTICS, INC.

Pharmaceutical Preparations·SAN DIEGO, CA

Financials

18 shown

Type	Period	Ended	Filed
10-Q	Q3 2024	9/30/24	11/14/24	→
10-Q	Q2 2024	6/30/24	8/12/24	→
10-Q	Q1 2024	3/31/24	5/15/24	→
10-K	FY 2023	12/31/23	4/1/24	→
10-Q	Q3 2023	9/30/23	11/13/23	→
10-Q	Q2 2023	6/30/23	8/14/23	→
↓

Earnings Releases (8-K)

19 shown

Filed	Period
11/14/24	Q4 FY2024	→
8/12/24	Q3 FY2024	→
5/15/24	Q2 FY2024	→
3/26/24	Q1 FY2024	→
11/13/23	Q4 FY2023	→
8/14/23	Q3 FY2023	→
↓

News (8-K)

61 shown

Filed	Type	Description
12/30/24	Agreement	Entry into a Material Definitive Agreement	→
12/10/24	Delisting	Notice of Delisting or Failure to Satisfy a Continued Listing Rule	→
11/15/24	Delisting	Notice of Delisting or Failure to Satisfy a Continued Listing Rule	→
10/29/24	Agreement	Entry into a Material Definitive Agreement	→
10/11/24	Vote	Material Modification to Rights of Security Holders	→
10/7/24	New Debt	Creation of a Direct Financial Obligation	→
↓

Prospectuses & Registrations

40 shown

Filed	Form	Description
10/29/24	424B5	424B5	→
10/29/24	424B3	424B3	→
10/29/24	424B3	424B3	→
10/29/24	424B3	424B3	→
10/29/24	424B3	424B3	→
10/29/24	424B3	424B3	→
↓

Filing History(428 filings)

TypeDateAccessionPeriodSize

SCHEDULE 13G/A

Aug 4, 2025

0000902664-25-003345

—

17.0 KB

SCHEDULE 13G

Aug 4, 2025

0001539497-25-002007

—

6.7 KB

SCHEDULE 13G/A

Jul 10, 2025

0001301396-25-000008

—

549.5 KB

25-NSE

Jun 4, 2025

0001354457-25-000496

—

4.1 KB

SCHEDULE 13D/A

Mar 26, 2025

0000950170-25-045642

—

19.4 KB

8-K

Dec 30, 2024

0001213900-24-113256CURRENT REPORT

Dec 27, 2024

529.3 KB

Dec 16, 2024

0000950170-24-1368294

Dec 12, 2024

21.1 KB

8-K

Dec 10, 2024

0000950170-24-1347558-K

Dec 10, 2024

164.9 KB

8-K

Nov 15, 2024

0000950170-24-1275688-K

Nov 13, 2024

489.1 KB

10-Q

Nov 14, 2024

0000950170-24-12706010-Q

Sep 30, 2024

10.7 MB

8-K

Nov 14, 2024

0000950170-24-1270308-K

Nov 14, 2024

452.8 KB

SC 13G

Nov 14, 2024

0000902664-24-006541

—

51.5 KB

8-K

Oct 29, 2024

0001193125-24-2466028-K

Oct 28, 2024

558.6 KB

424B5

Oct 29, 2024

0001193125-24-246212424B5

—

341.7 KB

424B3

Oct 29, 2024

0001193125-24-246203424B3

—

76.9 KB

424B3

Oct 29, 2024

0001193125-24-246201424B3

—

77.4 KB

424B3

Oct 29, 2024

0001193125-24-246197424B3

—

77.2 KB

424B3

Oct 29, 2024

0001193125-24-246189424B3

—

77.3 KB

424B3

Oct 29, 2024

0001193125-24-246181424B3

—

74.5 KB

DEF 14A

Oct 23, 2024

0001193125-24-241883DEF 14A

Nov 13, 2024

809.7 KB

PRE 14A

Oct 11, 2024

0001193125-24-236748PRE 14A

Nov 13, 2024

722.1 KB

8-K

Oct 11, 2024

0000950170-24-1142148-K

Oct 9, 2024

213.7 KB

SC 13D/A

Oct 9, 2024

0001193125-24-235295SC 13D/A

—

248.6 KB

UPLOAD

Oct 9, 2024

0000000000-24-011469

—

38.9 KB

8-K

Oct 7, 2024

0000950170-24-1132718-K

Oct 7, 2024

182.5 KB

25 filings shown

BIORA THERAPEUTICS, INC.

Financials

Earnings Releases (8-K)

News (8-K)

Prospectuses & Registrations

Filing History(428 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
10/23/24	DEF 14A	DEF 14A	→
10/11/24	PRE 14A	PRE 14A	→
9/16/24	DEF 14A	DEF 14A	→
9/3/24	PRE 14A	PRE 14A	→
4/24/24	DEFA14A	DEFA14A	→
4/24/24	DEF 14A	DEF 14A	→
↓

Filed	Form	Description
12/16/24	4	4	→
11/14/24	SC 13G	SC 13G	→
10/9/24	SC 13D/A	SC 13D/A	→
9/13/24	SC 13D/A	SC 13D/A	→
8/20/24	SC 13G	BIORA THERAPEUTICS, INC.	→
8/16/24	4	4	→
↓

Filed	Form	Description
8/4/25	SCHEDULE 13G/A	SCHEDULE 13G/A	→
8/4/25	SCHEDULE 13G	SCHEDULE 13G	→
7/10/25	SCHEDULE 13G/A	SCHEDULE 13G/A	→
6/4/25	25-NSE	25-NSE	→
3/26/25	SCHEDULE 13D/A	SCHEDULE 13D/A	→
9/3/24	EFFECT	EFFECT	→
↓